HPV technology applications presented at the HIS Conference 2014

Published: 24-Nov-2014

Bioquell HPV technology has recently been used in several places around the world for the decontamination of rooms or vehicles in which Ebola patients had been treated


Two presentations focusing on Bioquell’s hydrogen peroxide vapour (HPV) technology were presented at the biennial Healthcare Infection Society Conference 2014, which took place recently in Lyon, France. Attendees could learn how HPV inactivates pathogens on porous and non-porous surfaces and how this Bioquell technology has been used to decontaminate Ebola-exposed equipment and rooms.

Hospitals are confronted with the challenge of eliminating nosocomial pathogens such as C. diff., MRSA or VRE every day. These are difficult to eradicate by standard cleaning and disinfection methods. To prove the efficacy of HPV, the team involved in the study placed nosocomial pathogens onto stainless steel discs (hard non-porous surface) and cotton (soft porous surface) in an operating room. After three HPV cycles, the Bioquell ’no-touch’ automated room decontamination system had eliminated all MRSA, VRE and MDR A-baumannii from the surfaces.

Bioquell HPV technology has recently been used in several places around the world for the decontamination of rooms or vehicles in which Ebola patients had been treated. It was used for the terminal decontamination of the Royal Free London High Level Isolation Unit (HLIU) where the British healthcare worker repatriated from Sierra Leone with EVD was treated before being discharged. As explained in the presentation, 'The HPV decontamination was completed without incident, provided assurance that the HLIU was free from contamination, and returned the isolators to use'.

You may also like